Salute e Benessere

Evaxion to present preclinical Proof-of-Concept for precision ERV cancer vaccine…

/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will present preclinical Proof-of-Concept for its precision cancer vaccine concept, targeting non-conventional ERV (endogenous retrovirus) tumor antigens shared across patients at the ESMO Immuno-Oncology Congress, taking place from December 11-13, 2024, in Geneva, Switzerland.The data to be presented stems from studies in human cells and mouse tumor models. The studies...
Nasdaq GlobeNewswire
02/12/2024

Endo Launches ADRENALIN® Ready-to-Use Premixed Bag, the First and Only…

The ADRENALIN® premixed bag is the latest addition to Endo Injectable Solutions' TruDelivery® product line and platform. Ready-to-use products streamline operations for hospitals by eliminating the need to prepare or transfer the product before patient administration. This may reduce waste and costs, optimize convenience and workflow, and reduce the chance for preparation error—all of which support quality patient care. The ADRENALIN ®premixed bag is the latest addition to Endo Injectable...
PR Newswire
02/12/2024

Novo Nordisk A/S - share repurchase programme

Bagsværd, Denmark, 2 December 2024– On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period beginning 6 February 2024.Under…
Nasdaq GlobeNewswire
02/12/2024

MeditWave 2024 in Porto Brings Together Global Experts to Shape the Future of…

Hands-on courses and discussions at MeditWave covered topics such as "Solving Difficult Scanning Cases Together" and "Future Trends and Technologies of Intraoral Scanners." Medit product specialists guided participants through practical exercises, providing actionable insights into advanced scanning techniques. Hands-on courses and discussions at MeditWave covered topics such as "Solving Difficult Scanning Cases Together" and "Future Trends and Technologies of…
PR Newswire
02/12/2024

European Wellness Biomedical Group, Headed by Prof. Mike Chan, Releases New…

The study reveals that aging significantly affects stamina, endurance, and balance in athletes. Prof. Chan's vision is to help athletes overcome age-related limits and maintain peak performance. The study reveals that aging significantly affects stamina, endurance, and balance in athletes. Prof. Chan's vision is to help athletes overcome age-related limits and maintain peak performance. This comes aftera recent high-profile boxing matchwhere an aging legend faced a younger, more active...
PR Newswire
02/12/2024

Press Release: Sequana Medical announces update on second tranche of convertible…

SEQUANA MEDICAL ANNOUNCES UPDATE ON SECOND TRANCHE OF CONVERTIBLE BRIDGE LOANGhent, Belgium – 2 December 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, provides an update on the Convertible Bridge Loan previously reported on 30 September 2024. In connection with the Convertible Bridge Loan, the Company also entered into a (non-binding) letter of…
Nasdaq GlobeNewswire
02/12/2024

Nicox's Denali Phase 3 Trial of NCX 470 Fully Enrolled in China Earlier than…

Press ReleaseNicox's Denali Phase 3 Trial of NCX 470 Fully Enrolled in China Earlier than ExpectedConfirms topline results expected to be reported Q3 2025NCX 470 demonstrated robust efficacy and safety in topline results from first Phase 3 trial, Mont BlancNCX 470 partnering efforts will focus on routes for bringing the product to market in the U.S.Results from the NCX 470 Phase 3b Whistler Mechanism of Action trial expected in Q1 2025December 2, 2024 –...
Nasdaq GlobeNewswire
02/12/2024

Philips optimizes CT workflows with in-house AI, launches CT 5300 in North…

December 1, 2024Philips CT 5300 combines innovative hardware, software, and artificial intelligence to make high-quality screening, diagnostic, and interventional imaging accessible to more patients, including reading support with Automated AI-enabled Philips Advanced Visualization Workspace applicationsPhilips collaborates with Annalise.ai to evaluate streamlining workflows to prioritize time-sensitive casesAmsterdam, the Netherlands and Chicago, USA –Royal Philips(NYSE:...
Nasdaq GlobeNewswire
01/12/2024

Better care for more people: Philips innovates in AI-enabled imaging and…

Philips' intelligent diagnostic and treatment solutions, combined with its advanced capabilities in healthcare informatics, uniquely position the company to drive precision imaging for a greater number of patientsAmsterdam, the Netherlands and Chicago, USA –Royal Philips(NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled the company's latest AI-powered diagnostic and treatment imaging innovations to advance precise imaging with faster, easier and more...
Nasdaq GlobeNewswire
01/12/2024

CBC Group Completes Strategic Acquisition of UCB's Mature Product Portfolio in…

Fu Wei, Chief Executive Officer of CBC Group, said, "There is clear potential within the regional healthcare space to better serve patients with unmet medical needs in this growing CNS therapeutics market, and we are delighted to partner with Mubadala once again. This acquisition complements our existing healthcare ecosystem and aligns with our robust buyout strategy, which is strategically positioned to drive long-term, sustainable value in today's healthcare investing market. Together, we…
PR Newswire
30/11/2024

Report of transactions of shares and related securities of Bavarian Nordic by…

COPENHAGEN, Denmark, November 29, 2024– Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company's shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such.The transaction concerns the exercise of warrants by Thomas Bennekov, who has served as an employee-elected member of the Board of Directors of Bavarian Nordic since April 2021. The warrants were awarded to Mr...
Nasdaq GlobeNewswire
29/11/2024

Veterinary Medicine Market size worth $ 85.05 Billion, Globally, by 2031 at…

Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=202753 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=202753 202 - Pages 126 – Tables 37 – Figures Scope Of The Report Veterinary Medicine Market Overview 1. Market Size and Growth Potential The Veterinary Medicine Market was valued atUSD 46.51 billionin 2023 and is projected to reachUSD 85.05 billionby 2031, growing at a compound...
PR Newswire
29/11/2024

Active Pharmaceutical Ingredient Market Surges to USD 328.95 Billion by 2030…

Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=125142 Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=125142 Browse in-depth TOC on Active Pharmaceutical Ingredient Market 202 – Pages 126 – Tables 37 – Figures Scope of The Report Global Active Pharmaceutical Ingredient Market Overview Market Drivers Fueling Growth in the Active Pharmaceutical Ingredient Market To Purchase a Comprehensive...
PR Newswire
29/11/2024

Urinalysis Test Market Projected to Surge to USD 4.0 Billion by 2031, Driven by…

Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=1082691 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=1082691 202 - Pages 126 – Tables 37 – Figures Scope Of The Report Urinalysis Test Market Overview Market Size and Growth Rate : The global Urinalysis Test Market is projected to grow from approximatelyUSD 2.5 billionin 2024 to aroundUSD 4.0 billionby 2031, at a compound annual growth...
PR Newswire
29/11/2024

Static Compression Therapy Market Set for Significant Growth, valued at $2.61…

Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=527824 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=527824 202 - Pages 126 – Tables 37 – Figures Scope Of The Report Static Compression Therapy Market Overview 1. Market Size and Growth Potential The Static Compression Therapy Market is witnessing significant growth, valued atUSD 2.61 billionin 2023 and projected to reachUSD 4...
PR Newswire
29/11/2024

Narayana Health Issues Statement Regarding Spire Healthcare Group plc Under Rule…

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE “CODE”). BANGALORE, India, Nov.29, 2024(GLOBE NEWSWIRE) --Statement regarding Spire Healthcare Group plc (“Spire”) In response to recent media speculation,...
Nasdaq GlobeNewswire
29/11/2024

Major shareholder announcement

Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments.Per November 27, 2024, BlackRock, Inc. has adjusted its holding in Novonesis and now holds below 5% of total share capital attached to shares including share capital held through financial instruments (previously 5.05%)....
Nasdaq GlobeNewswire
29/11/2024

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial…

Attachments Notification of managers' transaction - Anthony RosenbergNotification of managers' transaction - Riad SherifNotification of managers' transaction - Sylvia CheungNotification of managers' transaction - Pall Johanesson
Nasdaq GlobeNewswire
29/11/2024

Brainomix Awarded for Its Breakthroughs with Transformative AI Imaging…

"We are honored to be recognized by LSX and OBN for these top awards, which reflect the transformative impact our technology is having on patient care globally," said Dr Michalis Papadakis, CEO and Co-Founder of Brainomix. "We remain committed to delivering cutting-edge AI solutions that will facilitate faster diagnosis and expand access to life-saving treatments for stroke and lung fibrosis patients." "We are honored to be recognized by LSX and OBN for these top awards…
PR Newswire
29/11/2024

Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise

COPENHAGEN, Denmark, November 29, 2024– Bavarian Nordic A/S (OMX: BAVA) announced today that the Company's share capital has been increased by nominally DKK 218,750 as a consequence of employees' exercise of warrants.The capital increase was effected without any pre-emption rights for the existing shareholders of the Company or others. A total of 21,875 new shares were subscribed for in cash at DKK 146.60 per share of nominally DKK 10. The total proceeds to Bavarian Nordic A/S from the...
Nasdaq GlobeNewswire
29/11/2024

K-wave goes mainstream in Southeast Asia but consumers now surf for localised…

Sunny Moon, Research Manager at Euromonitor International, said: "Beyond watching Korean content and travelling to Korea, consumers also incorporate K-products into their daily lives. However, they eventually prefer local products that align with local preference." Sunny Moon, Research Manager at Euromonitor International, said:"Beyond watching Korean content and travelling to Korea, consumers also incorporate K-products into their daily lives. However, they eventually prefer…
PR Newswire
29/11/2024

Follicular Lymphoma Clinical Trial Pipeline Appears Robust With 50+ Key Pharma…

LAS VEGAS, Nov. 28, 2024 /PRNewswire/ -- DelveInsight's 'Follicular Lymphoma Pipeline Insight 2024' report provides comprehensive global coverage of pipeline follicular lymphoma therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the follicular lymphoma pipeline domain. LAS VEGAS , Nov. 28, 2024 /PRNewswire/ -- DelveInsight's'Follicular Lymphoma Pipeline Insight 2024'...
PR Newswire
28/11/2024

Capnography Equipment Market to Hit USD 458.8 Million by 2029 with 4.2% CAGR |…

Browse in-depth TOC on "Capnography Equipment Market"150 - Tables50 - Figures245 - Pages Browse in-depth TOC on "Capnography Equipment Market" 150 - Tables 50 - Figures 245 - Pages Capnography accessories & disposables segment accounted for the largest share of the Capnography equipment market. Based on the product segment, the capnography accessories & disposable is segmented into CO2 sensors, sampling lines, Nasal cannulas, Filters, Adapters and connectors, among...
PR Newswire
28/11/2024

SKF develops first bearings designed for circular performance

The bearings are designed to withstand the most demanding applications depending on the material it is reclad with. For example, applying a stainless-steel alloy, means a normal bearing can be transformed into a corrosion resistant one, with the performance of a full solid stainless-steel bearing, at a comparatively lower cost. The bearings are designed to withstand the most demanding applications depending on the material it is reclad with. For example, applying a stainless-steel alloy,...
PR Newswire
28/11/2024
Altri  Comunicati